Cabozantinib and Pembrolizumab in Metastatic Pancreas

Condition:   Pancreatic Cancer Interventions:   Drug: Cabozantinib;   Drug: Pembrolizumab Sponsors:   Joseph Kim;   Exelixis;   Merck Sharp & Dohme Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials